Navigation Links
Less toxic combination of erlotinib and bevacizumab is effective non-small cell lung cancer patients
Date:6/1/2011

CHICAGO, IL (June 4, 2011)The standard treatment for patients with advanced non-small cell lung cancer (NSCLC) is a combination of two old-fashioned cytotoxic chemotherapy drugs. The combination, however, comes with substantial toxicity. Now, Fox Chase Cancer Center researchers report that a combination of two molecularly-targeted agents may provide similar therapeutic benefit with less toxicity.

"These results seem to be better than standard of care," says Hossein Borghaei, DO, medical oncologist at Fox Chase, who will present the results at the 2011 Annual Meeting of the American Society of Clinical Oncology on Saturday, June 4. "Of course, the problem with a phase II trial always is that the patients tend to be a select patient population. But when you look at the numbers, the patients appear to be benefiting from the treatment. They stay on treatment longer and the time to progression on average was a little bit better. And we don't have a lot of toxicities, like major hair loss or nausea, and we don't have a lot of neutropenia or anemia."

"So overall it looks like a well tolerated regimen and it appears to be an effective front-line therapy in this patient population," he says.

Until recently, clinicians assumed that older patients were more likely to suffer from serious toxicities associated with standard chemotherapy. Therefore, Borghaei's team focused their current study on patients 65 years and older, enrolling 33 patients with a median age of 74 years. All patients had previously untreated, advanced NSCLC. Patients received standard dose erlotinib (a small molecule inhibitor of the epidermal growth factor receptor) and bevacizumab (an antibody that blocks the vascular endothelial growth factor pathway) every 21 days until patients either progressed or stopped treatment due to adverse events.

Six patients remain on therapy and have received 4 to 40 cycles of treatment. Of the 24 patients off therapy, the median num
'/>"/>

Contact: Diana Quattrone
Diana.Quattrone@fccc.edu
215-728-7784
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gene-modified stem cells help protect bone marrow from toxic side effects of chemotherapy
2. Potentially Toxic Flame Retardants Found in Baby Products
3. Plastic products leach toxic substances
4. High levels of toxic compounds found on coasts of West Africa
5. The Dose Makes the Poison: A Plain-Language Guide to Toxicology, 3rd Edition
6. LED products billed as eco-friendly contain toxic metals, study finds
7. Red mud disasters main threat to crops is not toxic metals
8. Vegetarian Diet Cuts Kidney Patients Levels of Toxic Phosphorus
9. Toxic toy crisis requires fresh solutions
10. Discovery blocks cancer drugs toxic side effect
11. If the water looks and smells bad, it may be toxic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... May 18, 2013 Assisted living ... comes to safety and comfort of their residents. ... provides clients with an effective and cost-efficient solution ... is an integrated, turnkey communications solution that helps ... allowing residents independence and privacy. , The ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Today, ... insurance agents’ role in Marketplaces . Zane ... traditional employer sponsored health benefits, is the leader ... and health reimbursement arrangements . , According ... and Human Services (HHS) recently released a much-anticipated ...
(Date:5/18/2013)... FL (PRWEB) May 18, 2013 The ... to the special places we call home. These are the ... maps. They are the locations where the people are friendly ... show takes viewers off the highways and shares the best ... of both nations with an American sports and film celebrity. ...
(Date:5/18/2013)... “World Healthcare IT Market: Trends & Forecast (2010 – ... and opportunities in North America, Europe, Asia, & Rest ... 89 market data tables , 20 ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers will ... IT market is expected to grow from $99.6 billion ...
(Date:5/18/2013)... 2013 TheBeautyPlace.com answers important questions about ... is not a result of stress, nutrient deficiency or ... Magazine, 70% of men suffer from male patterned baldness. ... renowned for hair transplant surgery, but additionally carries a ... known as Bosley Professional Strength. Their product line is ...
Breaking Medicine News(10 mins):Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3
... The Cosmetic Bootcamp LLC, the leading training ... is pleased to announced reduced tuition scholarships for ... resident in dermatology, plastic surgery, ophthalmology, oculoplastic surgery, ... economic conditions, the sponsors for the meeting have ...
... for millionsBIRMINGHAM, Ala., April 28 As many as 17.8 ... 2050 and 1.57 million will be blind from the disease, ... However, a new medical study by a group of ... University of Alabama Birmingham (UAB) indicates that with ...
... Md. (April 24, 2009) The Henry M. Jackson Foundation ... a one-of-a-kind publication intended to educate anesthesiology residents in ... techniques and acute pain medicine. Its aim is to ... combat trauma. , " The Military Advanced Regional ...
... Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... president and chief executive officer, Hill-Rom. He will be ... New York City on Wednesday, May 13, 2009 at 2 ... via the internet link at http://ir.hill-rom.com/events.cfm ...
... BMP,Sunstone Corporation (Nasdaq: BJGP ) ("BMP Sunstone" ... Baledge to its board of directors following,the Company,s annual ... Mr. Baledge has over two decades ... Mr. Baledge served as Executive Vice President and General,Counsel ...
... Annual Meeting , CHICAGO, April 28 Endo Pharmaceuticals ... clinical trial data in men with hypogonadism who were ... 750 mg) injection, a long-acting testosterone replacement therapy in ... Results showed that average testosterone levels were maintained within ...
Cached Medicine News:Health News:New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement 2Health News:HJF publishes handbook on managing pain of battlefield trauma 2Health News:Hill-Rom to Present at the Bank of America 2009 Health Care Conference 2Health News:BMP Sunstone Appoints Les R. Baledge to Board of Directors 2Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 2Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 3Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 4Health News:Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show 5
(Date:5/16/2013)...  Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
(Date:5/16/2013)... -- OrthoView PSL will allow individual surgeons ... widely-used OrthoView digital templating software via the Cloud and ... started. OrthoView, the leading independent provider of ... dedicated to enabling orthopaedic surgeons in hospitals and private ... film is unavailable. Over 5,000 orthopaedic surgeons in the ...
(Date:5/16/2013)... Developers of a pill bottle that wirelessly transmits ... grand prize winners in the Healthcare Innovation World Cup ... and organized by HITLAB . Winning team ... Langhauser and Mike Morena ... States will receive $50,000 in prize money. They ...
Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 2Wireless Pill Bottle Wins Healthcare Innovation World Cup 3Wireless Pill Bottle Wins Healthcare Innovation World Cup 4Wireless Pill Bottle Wins Healthcare Innovation World Cup 5
... CLARA, Calif., March 7, 2011 Samplify Systems, Inc., ... medical, industrial, wireless, and scientific markets, has completed its ... enables the company to fund its rapid growth in ... new markets.  Participating in the round are Integrated Device ...
... plc (Nasdaq: WCRX ) today announced that its ... scheduled to speak at the Goldman Sachs Leveraged Finance Healthcare ... The presentation will be simultaneously webcast at ... available shortly thereafter at http://ir.wcrx.com/events.cfm . ...
Cached Medicine Technology:Samplify Systems Completes Series B Funding 2Samplify Systems Completes Series B Funding 3
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Plastic Citrate Tube, .109M / 3.2%...
Medicine Products: